Houston, Texas — According to state and local economic development sources Neurogene plans to invest $10,000,000.00 to build out 24,800 square feet of new space in Houston. The company plans to occupy the new space at 10301 Stella Link Rd. Suite a in Houston, on or about September 1, 2021. According to the company website Neurogene is accelerating development of new genetic medicines to people with devastating neurological diseases and their families. To do this, we are working with experts across the globe to advance a broad pipeline of programs to treat the underlying cause of serious neurological disorders and thereby address the overwhelming need for new therapies.

To learn more about Neurogene, visit http://www.neurogene.com/

Company Contact:
Rachel McMinn, Chief Executive Officer
https://www.linkedin.com/in/rachel-mcminn-b0576415b/
877-237-5020

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved